Volume 1; Issue supp-S1

Main
Clinical Breast Cancer
Volume 1; Issue supp-S1

Clinical Breast Cancer

Volume 1; Issue supp-S1

1

Introduction

Martine J. Piccart

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 35 KB

english, 2000

2

Antiaromatase Agents: Preclinical Data and Neoadjuvant Therapy

William R. Miller, J. Michael Dixon

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 217 KB

english, 2000

3

Exemestane Improves Survival in Metastatic Breast Cancer: Results of a Phase III Randomized Study

Manfred Kaufmann, Emilio Bajetta, Luc Yves Dirix, Luis Enrique Fein, Stephen E. Jones, Nicoletta Zilembo, Jean-Louis Dugardyn, Cristina Nasurdi, Robert G. Mennel, Jozica Cervek, Camilla Fowst, Anna Po

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 102 KB

english, 2000

4

Promising Results with Exemestane in the First-Line Treatment of Metastatic Breast Cancer: A Randomized Phase II EORTC Trial with a Tamoxifen Control

Robert Paridaens, Luc Dirix, Louk Beex, Marianne Nooij, Tania Cufer, Caroline Lohrisch, Laura Biganzoli, Irène Van Hoorebeeck, Luc Duchateau, Jean-Pierre Lobelle, Martine Piccart

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 93 KB

english, 2000

5

Antiaromatase Agents After Adjuvant Tamoxifen: Rationale and Clinical Implications

Eleftherios P. Mamounas

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 117 KB

english, 2000

6

Exemestane in Breast Cancer: Current Status and Future Directions

Per E. Lønning

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 119 KB

english, 2000

7

Rationale and Use of Epirubicin-Based Therapy in the Adjuvant Setting

Henning T. Mouridsen

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 120 KB

english, 2000

8

Overview of Epirubicin-Based Adjuvant Therapy in Breast Cancer

Michael Untch, Franz von Koch, Steffen Kahlert, Gottfried Konecny

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 131 KB

english, 2000

9

Role of Epirubicin in Advanced Breast Cancer

Pier Franco Conte, Alessandra Gennari, Elisabetta Landucci, Cinzia Orlandini

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 114 KB

english, 2000

10

Rationale and Design of a Phase III Trial of Adjuvant Sequential Epirubicin/Cyclophosphamide and Taxane Versus Concurrent Epirubicin/Taxane in Operable Node-Positive Breast Cancer

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 116 KB

english, 2000

11

Selection Criteria for Epirubicin-Based Adjuvant Chemotherapy in Node-Negative Breast Cancer

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 245 KB

english, 2000

12

Epirubicin in Breast Cancer: Present and Future

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 120 KB

english, 2000

13

Comparison of In Vitro Exemestane Activity Versus Other Antiaromatase Agents

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 106 KB

english, 2000

14

Treating Breast Precancer

Joyce A. O'Shaughnessy

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 129 KB

english, 2000

15

The Role of Vascular Endothelial Growth Factor (VEGF) in Tumor Angiogenesis and Early Clinical Development of VEGFReceptor Kinase Inhibitors

Henk M.W. Verheul, Herbert M. Pinedo

Journal:

Clinical Breast Cancer

Year:

2000

Language:

english

File:

PDF, 82 KB

english, 2000